Cytomegalovirus Retinitis

Drug Implant Approved To Treat CMV in AIDS Patients

Published in AIDS Weekly, April 29th, 1996

Ophthalmology researchers at the University of Texas (UT) Southwestern Medical Center at Dallas have received approval to use an anti-viral eye implant they pioneered to treat active cytomegalovirus (CMV) retinitis.

The U.S. Food and Drug Administration (FDA) approved the device, which delivers a steady dose of the drug ganciclovir sodium directly into the eye infected with CMV. CMV infection also occurs, although less frequently, in organ-transplant patients taking immunosuppressive drugs.

"CMV has a tendency to infect the retina and destroy it. Since the retina is the light sensing tissue in the eye, CMV infection there can cause permanent,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1996-04-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry